Joe Eid

Trials

Studies that name Joe Eid as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:39 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT04576156 · A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

  Geron Corporation · active not recruiting · Myelofibrosis · study director
• Ph2
  NCT01242930 · Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma

  Geron Corporation · completed · Multiple Myeloma · study director

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 20 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.